Resolute Integrity US Extended Length Sub-Study(RI US XL)
Completed · Not applicable
Conditions studied: Coronary Artery Disease
In brief
Prospective, multi-center, non-randomized, single-arm, open-label study to assess the safety and efficacy of the Resolute Integrity Stent for the treatment of de novo lesions in native coronary arteries with a reference vessel diameter (RVD) of 2.25 mm to 4.2 mm in patients who receive extended length stents (34 mm or 38 mm) referred to as the Extended Length Study.
Key facts
- Study ID
- NCT01913600
- Run by
- Medtronic Vascular
- People needed
- 56
- Starts
- 2013-07-01
- Expected to finish
- 2018-12-01
- Last updated by the study team
- 2019-05-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- St. Joseph's Hospital Health Center — Syracuse, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.